A 71-year-old Chinese patient was diagnosed with liver cancer. Because the tumor was adjacent to major blood vessels and the patient was elderly and physically weak, he visited multiple hospitals over three years and was repeatedly told that surgery was not possible and that he could not tolerate chemotherapy. No effective treatment options remained. After being referred to Uni-Asia Cancer Hospital, he underwent three sessions of transarterial chemoembolization (TACE). He recovered smoothly after the procedures, and follow-up examinations showed that the tumor had almost disappeared, achieving clinical cure. He has now returned to his orchard and resumed normal life.

A Chinese patient was diagnosed with liver cancer accompanied by severe bile duct obstruction, severe systemic jaundice, and a weight loss of nearly 15 kg within one month. His bilirubin level was as high as 257.50 umol/L. Because the tumor was adjacent to major blood vessels, several hospitals assessed that surgical resection would carry an excessively high risk. After being referred to UNI-ASIA Cancer Hospital, he underwent two interventional treatments. He recovered quickly after the procedures, was able to get out of bed the next day, his jaundice subsided, his weight stabilized, and he has now returned to normal life.

A 9-year-old Chinese girl was diagnosed with a massive tumor in the second hepatic portal region of the liver. Due to its proximity to major blood vessels, multiple hospitals deemed it inoperable. Her family then brought her to Chengdu Uni-Asia Hospital, where Professor Liao Zhengyin's team, after multidisciplinary discussion, formulated a precise, minimally invasive interventional treatment plan and successfully performed the procedure. The patient adhered to regular follow-ups as advised. Imaging surveillance showed complete tumor regression, with no recurrence for 17 consecutive years and all parameters remaining normal. Today, she has graduated with honors as an outstanding university student and is now working professionally, enjoying a long-term, high-quality life.

70 years old, retired professor from the University of Geosciences, with a 35-year history of hepatitis B. In May 2025, he was diagnosed with a massive hepatocellular carcinoma in the left lobe of the liver, measuring 12 cm in diameter, accompanied by ascites, moderate anemia, and severe liver dysfunction. After being transferred to Chengdu UNI-ASIA Hospital, Professor Liao Zhengyin’s team performed hepatic arterial angiography with infusion and embolization therapy in two sessions. Two months later, follow-up examination showed that the tumor had shrunk to 6 cm, the ascites had significantly subsided, and liver function had markedly recovered. He has now returned to normal life.

Chinese female patient, 41 years old, with a solitary large mass of hepatocellular carcinoma in the right lobe of the liver. The tumor compressed the bile duct, causing severe jaundice. Due to the tumor's large size and unfavorable location, surgical resection was not possible. The patient had previously undergone radiotherapy and chemotherapy at another hospital, but with poor response and severe toxic side effects, including nausea, vomiting, and bone marrow suppression, making further treatment impossible. A multidisciplinary team (MDT) at Chengdu Uni-Asia Cancer Hospital conducted a consultation and performed two sessions of hepatic arterial interventional therapy after the referral. The patient recovered rapidly post-surgery, jaundice subsided, and pre- and post-treatment CT comparisons showed tumor volume reduced by over 70% with loss of viability. The patient has regained the ability to live independently and returned to her daily family life.

Chinese national, 78-year-old female, diagnosed with hilar cholangiocarcinoma presenting with systemic jaundice. After undergoing PTCD drainage at an outside hospital, her jaundice temporarily improved. However, due to the tumor's challenging location and her advanced age, surgery, radiotherapy, and chemotherapy were not feasible. After referral to Chengdu Uni-Asia Cancer Hospital, a multidisciplinary team developed an individualized interventional plan, and she underwent two sessions of transarterial chemoembolization (TACE). Post-treatment, the tumor significantly shrank, bile drainage was restored, her stool color returned from clay-white to normal yellow, her appetite recovered, her mental status markedly improved, the drainage tube was removed, and she returned to a peaceful, later-life routine.

A 42-year-old Filipino patient was diagnosed with primary liver cancer with intrahepatic metastases and a tumor thrombus in the inferior vena cava (stage IV), and had lost the opportunity for surgical resection. He was referred to Chengdu Uni-Asia Hospital through an international referral center. Professor Luo Xiaoping’s team first performed biliary drainage to relieve jaundice, and after his condition stabilized, carried out hepatic arterial infusion chemotherapy and embolization to control the tumor. After the procedure, his abdominal distension was significantly relieved; he was able to get out of bed the next day and was successfully discharged to return home.

A Chinese patient was diagnosed with liver cancer accompanied by metastasis to the C3 cervical vertebra and a pathological fracture. On admission, he had severe neck pain and markedly limited movement. The Uni-Asia team first performed cervical vertebroplasty to stabilize the vertebra and relieve pain, and on the following day performed transarterial chemoembolization of the hepatic artery to control the intrahepatic tumor. After surgery, his pain was significantly relieved; he was able to get out of his wheelchair and walk, and he was in good spirits at discharge.